Vireo Growth (VREOF) Non-Current Debt (2021 - 2026)

Vireo Growth's (VREOF) quarterly Non-Current Debt came in at $197.3 million in Q1 2026, up 215.16% year-on-year from $62.6 million in Q1 2025, and up 54.62% quarter-over-quarter from $127.6 million in Q4 2025.

Vireo Growth (VREOF) Non-Current Debt (2021 - 2026) Analysis & Trends

Vireo Growth has disclosed Non-Current Debt across 6 years of filings, most recently posting $197.3 million for Q1 2026.

  • Non-Current Debt for Q1 2026 came in at $197.3 million, up 215.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $197.3 million (up 215.16% YoY), and the FY2025 annual result was $127.6 million, up 104.82% from the prior year.
  • Non-Current Debt came in at $197.3 million for Q1 2026 at Vireo Growth, up from $127.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $197.3 million in Q1 2026 to a low of $1.1 million in Q2 2024.
  • The 5-year median for Non-Current Debt is $56.0 million (2023), against an average of $63.6 million.
  • Across the five-year window, Non-Current Debt tumbled 91.82% in 2023 and surged 7232.02% in 2025, its largest moves.
  • Vireo Growth's Non-Current Debt stood at $46.2 million in 2022, then surged by 30.21% to $60.2 million in 2023, then advanced by 3.45% to $62.3 million in 2024, then surged by 104.82% to $127.6 million in 2025, then soared by 54.62% to $197.3 million in 2026.
  • The last three Non-Current Debt figures came in at $197.3 million (Q1 2026), $127.6 million (Q4 2025), and $131.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 14.02 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 9.05 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 3.92 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.48 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 569.60 Mn
10 Vireo Growth - - 59.30 Mn 197.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 197.30 Mn
Mar 31, 2026 197.30 Mn
Dec 31, 2025 127.60 Mn
Dec 31, 2025 127.60 Mn
Sep 30, 2025 131.67 Mn
Sep 30, 2025 131.67 Mn
Jun 30, 2025 82.21 Mn
Jun 30, 2025 82.21 Mn
Mar 31, 2025 62.60 Mn
Mar 31, 2025 62.60 Mn
Dec 31, 2024 62.30 Mn
Dec 31, 2024 62.30 Mn
Sep 30, 2024 56.83 Mn
Sep 30, 2024 56.83 Mn
Jun 30, 2024 1.12 Mn
Jun 30, 2024 1.12 Mn
Dec 31, 2023 60.22 Mn
Dec 31, 2023 60.22 Mn
Sep 30, 2023 4.06 Mn
Sep 30, 2023 4.06 Mn